Quick Answer
CRESCENT BIOPHARMA, INC. reported Net Income of -$153.94 million for fiscal year 2025.
CRESCENT BIOPHARMA, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$153.94M | -306.4% |
| 2024 | -$37.88M | -2.7% |
| 2023 | -$36.90M | +21.0% |
| 2022 | -$46.69M | +26.4% |
| 2021 | -$63.43M | -24.3% |
| 2020 | -$51.03M | +11.9% |
| 2019 | -$57.89M | -19.9% |
| 2018 | -$48.27M | -45.0% |
| 2017 | -$33.28M | -4.6% |
| 2016 | -$31.81M | -149.1% |
| 2015 | -$12.77M | -14.8% |
| 2014 | -$11.12M | -4.9% |
| 2013 | -$10.61M | -390.1% |
| 2012 | $3.66M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$24.61M | -835.3% | -12.9% |
| June 30, 2025 | -$21.79M | -115.8% | -43.8% |
| March 31, 2025 | -$15.15M | -41.1% | -475.8% |
| September 30, 2024 | -$2.63M | +71.4% | +73.9% |
| June 30, 2024 | -$10.10M | -22.2% | +6.0% |
| March 31, 2024 | -$10.74M | -3.6% | -16.7% |
| September 30, 2023 | -$9.20M | -8.0% | -11.4% |
| June 30, 2023 | -$8.26M | +37.8% | +20.3% |
- CRESCENT BIOPHARMA, INC. showed a decrease of -306.4% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, CRESCENT BIOPHARMA, INC.’s net income has declined by 4310.6% (from $3.66 million to -$153.94 million).
- The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: